VICTORIA, Nov. 23 /CNW/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV - News; TSX: ASV - News) today announced that meeting materials regarding a special meeting to consider the proposed statutory plan of arrangement (“Arrangement”) with Galenica Group (SWX: GALN - News) have been mailed to Aspreva shareholders and optionholders of record. Copies of the meeting materials, including the management information circular and forms of proxy, are available on the United States Securities and Exchange Commission’s website at www.sec.gov, and on the Canadian provincial securities authorities SEDAR website at www.sedar.com.
